A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
Instituto Grifols, S.A.
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
First received: March 16, 2012
Last updated: June 15, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2016|
|Estimated Primary Completion Date:||December 2016 (Final data collection date for primary outcome measure)|